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One major bottleneck in the ongoing COVID‑19 pandemic is the limited number of critical care beds. 
Due to the dynamic development of infections and the time lag between when patients are infected 
and when a proportion of them enters an intensive care unit (ICU), the need for future intensive care 
can easily be underestimated. To infer future ICU load from reported infections, we suggest a simple 
statistical model that (1) accounts for time lags and (2) allows for making predictions depending 
on different future growth of infections. We have evaluated our model for three heavily affected 
regions in Europe, namely Berlin (Germany), Lombardy (Italy), and Madrid (Spain). Before extensive 
containment measures made an impact, we first estimate the region‑specific model parameters, 
namely ICU rate, time lag between infection, and ICU admission as well as length of stay in ICU. 
Whereas for Berlin, an ICU rate of 6%, a time lag of 6 days, and a stay of 12 days in ICU provide the 
best fit of the data, for Lombardy and Madrid the ICU rate was higher (18% and 15%) and the time 
lag (0 and 3 days) and the stay in ICU (3 and 8 days) shorter. The region‑specific models are then used 
to predict future ICU load assuming either a continued exponential phase with varying growth rates 
(0–15%) or linear growth. By keeping the growth rates flexible, this model allows for taking into 
account the potential effect of diverse containment measures. Thus, the model can help to predict 
a potential exceedance of ICU capacity depending on future growth. A sensitivity analysis for an 
extended time period shows that the proposed model is particularly useful for exponential phases of 
the disease.
The number of reported COVID-19 cases worldwide is steadily increasing and has almost reached 100 million 
in January  20211. Most infections have been reported in the U.S. (almost 25 million) but also European countries 
including France, Italy, UK, Spain, and Germany have been strongly affected. Even though these numbers depend 
on the number of conducted tests, they demonstrate the huge spread and severity of the SARS-CoV-2 pandemic.
It lies in the nature of exponential growth that it starts slowly and bears the risk that the future development 
is underestimated, as shown in multiple psychological  studies2. In the SARS-CoV-2 pandemic, this leads to the 
risk of underestimating case fatality  rates3,4 but also the risk that the health system might be overburdened due to 
a too high number of patients in intensive care units (ICUs)5. Although it is well-known that a certain number of 
COVID-19 patients needs intensive care, especially elderly people and people with pre-existing  conditions6, the 
exponential dynamics of infections along with the time lag between the number of reported infections and the 
number of ICU patients can lead to the false impression that the amount of ICU patients will be  unproblematic3,7. 
Due to the lag and ICU durations of one to several weeks, even when the exponential growth of infections is 
stopped, it takes a while until the pressure on ICUs is  reduced8–10.
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In several regions including Lombardy (Italy) and Madrid (Spain), the need for ICUs surpassed the available 
capacity and not all COVID-19 patients who needed intensive care could be  treated5,11,12. To slow down the 
spread of the disease and to avoid a triage, several countries, including Germany, Italy, and Spain, decided to 
apply containment measures—ranging from temporary closures of schools and kindergartens to travel restric-
tions, compulsory mask wearing, and curfew. Those measures, however, disrupt economic activity and lead to 
the risk of a recession. Thus, policymakers are confronted with the difficulty of making decisions that severely 
affect the healthcare system, the global economy as well as the everyday life of many individuals while facing 
a large amount of uncertainty within the SARS-CoV-2 pandemic (e.g., the time until new treatments or vac-
cinations have been developed and are available at a large scale). Since one major bottleneck for the healthcare 
system is the ICU capacity, risk models are needed that allow policymakers to estimate the future ICU load to 
take appropriate measures.
So far, most forecast models for ICU load fit exponential growth (e.g., using ordinary least-squares in the 
log-space) to either the cumulated number of positive COVID-19 patients or directly to the number of ICU 
 patients5,13,14. For different regions in the UK, regional ICU capacities have been predicted using a Monte Carlo 
 simulation13. Those models, however, assume that the initial exponential growth will hold over the forecast 
horizon (usually 14 days) and do not account for the alleviation of growth rates, e.g., due to containment meas-
ures. Moreover, these models do not exploit the underlying relationship between reported infections and ICU 
admissions, e.g., in terms of ICU rate.
In this study, we suggest a simple and transparent statistical model that is able to account for (1) the time 
lag between reported infection and ICU admission and (2) different future growth (linear or exponential). This 
allows us in particular to predict the time point when the ICU load exceeds a given capacity. We address the 
following research questions: Can the future number of ICU patients be predicted from the number of reported 
infections? And how does the growth rate influence the time when ICU capacity is expected to be overburdened?
In our main analysis, we apply the model to public data sets for three regions, namely Berlin (Germany), 
Lombardy (Italy), and Madrid (Spain). All three regions have been strongly affected by the SARS-CoV-2 pan-
demic and data on ICU patients as well as the initial number of ICU beds were publicly available. Based on 
the total number of COVID-19 patients and the number of COVID-19 patients in ICUs, we first estimate the 
parameters of the model (i.e., ICU rate, length of stay in ICU, and time lag between the positive testing and the 
ICU admission). We restrict here the data to the first wave of infections and the time period before extensive 
containment measures made an impact. And second, we predict for a time horizon of 2 months the number 
of COVID-19 patients who need intensive care when assuming linear or exponential growth of the number of 
reported infections. By incorporating the dependency between the total number of COVID-19 patients and 
COVID-19 patients in ICUs as well as holding growth rates flexible, our model extends previous models and 
accounts for differential effects of potential containment measures. The predictions of our model in combination 
with epidemiological estimates regarding disease dynamics can be used in turn to predict future ICU load and 
to potentially infer when the ICU load will exceed a given capacity. In an additional analysis, we investigate the 
sensitivity of our proposed model with respect to different phases in the pandemic. For this, we extend the time 
series of all regions until December 2020 and estimate the parameters separately for each month.
Method
In this section, we introduce the theoretical model for predicting the number of ICU patients based on the 
number of reported infections. Denote PTt the total number of positively tested people until day t in a particu-
lar region. PTt = PTt − PTt−1 is then the number of newly positively tested people only on day t. A certain 
share αl of the newly positively tested people needs intensive care l days later with lag l, l = 1, . . . , L , and some 
maximum lag L denoting the maximal duration between a positive test and ICU admission. Moreover, patients 
remain in intensive care for a longer time, which means that ICU admissions of the previous days also have to 
be considered. In early stages of a disease, the exact distribution of the lengths of ICU stays might not be avail-
able and for simplification, the duration can be modelled as constant for all patients. We denote K the number 
of days patients remain in an ICU.
The number of ICU patients at time t can then be predicted in dependence of K and a vector αl with 
l = 1, . . . , L , which contains the probabilities that positively tested persons have transited to ICU after l days, 
in the following way:
In case only the overall share of reported infected people needing intensive care is available (without dif-
ferentiating between the lags), the so-called ICU rate α with α =
∑
L
l=1 αl , this can be used in combination with 
a specific lag l∗ . Eq. (1) then becomes:
Since Eq. (2) corresponds to the data situation in our empirical application, the subsequent considerations 
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To evaluate the performance of the models and to derive the parameters ICU rate α , the length of ICU stay 
K and the lag length l∗ that best explain the data, the squared correlation coefficient and the root mean squared 
prediction error (RMSE) for each model can be calculated by comparing the predicted value ÎCt(K ,α, l∗) to the 
observed value ICt . The RMSE is defined as
with T denoting the number of days with observations available. The model with the lowest RMSE is supposed to 
fit best to the observed data. Since the RMSE depends on the level of the variable to be predicted, we also provide 
the normalized RMSE (nRMSE) by dividing the RMSE by the variable mean. This results in a percentage error 
and facilitates comparing the results for different regions.
Containment measures and other factors including testing capacity and the age distribution of infected people 
can influence Eqs. (1)–(3) in several ways. For instance, while successful containment decreases the number of 
positively tested people PTt , an extended testing capacity in turn increases PTt . Moreover, containment measures 
and testing capacity can lead to structural breaks in the parameter estimates. For example, a better protection of 
people with pre-existing conditions or elderly people as well as a higher testing capacity could lead to a reduced 
ICU rate α due to an increased share of mild cases. In addition, the testing capacity and resulting timing of tests 
influence the time lag l, and the length of stay in ICU depends on the occupancy rates in the hospitals, which in 
turn can be influenced by successful containment.
After the parameters K, a, and l∗ are estimated (based on prior knowledge or data), they can be used to 
predict the future development by assuming either linear growth with slope d for the number of infections, i.e., 
PTt+1 = PTt + d , or exponential growth with rate r for the number of infections, i.e., PTt+1 = (1+ r)PTt . By 
allowing flexible linear and exponential growth, the model indirectly accounts for the effect of different con-
tainment measures. The predicted number of ICU patients can then be compared with different levels of ICU 
capacities. Moreover, dates when a given capacity is expected to be exceeded can be calculated.
Empirical application for early phase
We now apply the above introduced theoretical model to data of the initial phase (March/April 2020) of the 
SARS-CoV-2 pandemic for Berlin (Germany), Lombardy (Italy), and Madrid (Spain). In a first step, we deter-
mine the parameters K, a, and l∗ that best explain the data in each region. We then use this model to predict the 
number of ICU patients for a fixed time horizon of 2 months assuming further linear or exponential growth. 
Please note that the model is sensitive to the estimated parameters and the underlying data. In particular, we 
demonstrate here the sensitivity of the development regarding future growth and different time periods within 
the SARS-CoV-2 pandemic.
Data. Berlin (Germany). Berlin (Germany) is one of the 16 federal states of Germany and is densely popu-
lated with currently about 3.8 million  inhabitants15. For each day between March 1 and April 21, we retrieved 
the number of reported COVID-19 patients and the number of COVID-19 patients in ICUs for Berlin from the 
Berlin Senate Department for Health, Nursing and Equal Opportunities (https ://www.berli n.de/sen/gpg/servi ce/
press e/2020/; Fig. 1, top left). The total number of COVID-19 infections increased from one on March 1, 2020, 
to 5341 on April 21, 2020. The first patients in intensive care (three) were reported on March 16, 2020, and this 
number increased to 164 on April 21, 2020. Figure 1 (top right) depicts the (absolute and relative) daily change 
in the number of reported infections over the previous 7 days since the first day more than 100 cases were re-
ported (March 12, 2020, 118 cases). This averaging rules out weekend effects when some numbers are reported 
with delay.
On March 23, 2020, extensive containment measures including school closure and contact restriction were 
established for  Berlin16. To make the three regions comparable and to ensure a greater homogeneity of the data, 
we restrict our analysis to the period before containment measures make an impact. For Berlin, we therefore 
include only data from March 1, 2020, to March 30, 2020. The end date corresponds to 7 days after the lockdown. 
The overall daily growth rate for this period (with a minimum of 100 cases) is 19% , but it decreased to 11% in 
the last week.
The deployment of ICU beds is a highly dynamic process. According to the health senator of Berlin, Dilek 
Kalayci, the number of ICU beds in Berlin was 1045 in March 2020 and has been planned to increase to 2267 
until the end of  April17,18. Based on this, we define the following capacity limits for Berlin: (1) current maximal 
capacity (1045 ICU beds) and (2) extended capacity by the end of April (2267 ICU beds).
Lombardy (Italy). Lombardy is one of the 20 administrative divisions of Italy and has about 10 million 
 inhabitants19. For each day between February 24, 2020, and April 21, 2020, we retrieved the number of reported 
COVID-19 patients and the number of COVID-19 patients in ICUs for Lombardy from the Presidenza del 
Consiglio dei Ministri—Dipartimento della Protezione Civile (https ://githu b.com/pcm-dpc/COVID -19; Fig.  1, 
middle left). The total number of COVID-19 infections increased from 166 on February 24, 2020, to 67,925 on 
April 21, 2020. The number of ICU patients increased from 19 on February 24, 2020, to 1381 on April 3, 2020. 
Since then, it decreased to 851 on April 21, 2020. Figure 1 (middle right) depicts the daily (absolute and relative) 
change in the number of reported infections over the previous 7 days. On March 8, 2020, Italian Prime Minister 
Giuseppe Conte put the whole Lombardy under  quarantine20. Assuming that at least 7 days are needed before 
the quarantine makes an impact, we restrict our analysis to data from February 24, 2020 to March 15, 2020. The 
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overall daily growth rate for this period (with a minimum of 100 cases) is 23% and it decreased to 21% in the 
week between March 8, 2020, and March 15, 2020.
Before the SARS-CoV-2 pandemic, the ICU capacities in Lombardy were estimated to be 720  beds5, however, 
some hospitals have increased their number of ICU beds by the factor of 4–5 during the pandemic.
Madrid (Spain). Madrid is one of the 17 autonomous communities in Spain and has about 6.6 million 
 inhabitants21. For each day between February 25, 2020, and April 21, 2020, we retrieved the number of reported 
COVID-19 patients and the number of COVID-19 patients in ICUs for Lombardy from Datadista (https ://githu 
b.com/datad ista/datas ets; Fig. 1, bottom left). The total number of COVID-19 infections increased from two on 
February 25, 2020, to 59,199 on April 21, 2020. The number of ICU patients increased from 53 on March 3, 2020, 
to 1528 on April 1, 2020. Since then, it decreased to 1024 on April 21, 2020. Figure 1 (bottom right) depicts the 
daily (absolute and relative) change in the number of reported infections over the previous 7 days.
Figure 1.  Number of reported infections and intensive care patients (left) and absolute and relative daily change 
of the number of infections (right, averaged over the last 7 days, since 100 infections) in Berlin, Lombardy, and 
Madrid; based on data from the Berlin Senate Department of Health, Nursing and Equal Opportunities (Berlin), 




Scientific Reports |         (2021) 11:5018  | https://doi.org/10.1038/s41598-021-83853-2
www.nature.com/scientificreports/
On March 14, 2020, the Prime Minister of Spain Pedro Sánchez declared a nationwide State of Alarm and a 
national lockdown was  imposed22. Also for Madrid, we restrict our analysis to data until 7 days after the lock-
down. Hence, our data set ranges from February 25, 2020, to March 21, 2020. The overall daily growth rate for 
this period (with a minimum of 100 cases) is 31% and it increased to 54% in the week between March 7, 2020, 
and March 14, 2020.
An ICU capacity of 540 beds has been reported before the SARS-CoV-2 pandemic, during the pandemic this 
number has been  tripled23,24.
Results. We estimated the parameters of the model separately for Berlin, Lombardy, and Madrid (see Table 1). 
For Berlin, the best fit was found for an ICU rate α of 6%, a time lag of 6 days, and a stay of 12 days in ICU. For 
Lombardy and Madrid, in contrast, a better fit was found for larger ICU rates (18% and 15%), shorter ICU stays 
(3 and 8 days), and a shorter time lag (0 and 3 days). The RMSE for Berlin is considerably lower than for Lom-
bardy and Madrid, which can be explained by the lower number of ICU patients. If the RMSE is normalized by 
the average number of ICU patients in the considered period, it corresponds to 18% (Lombardy), 21% (Berlin), 
and 25% (Madrid). The squared correlation coefficient lies between 0.97 and 0.98 for all three regions. In Fig. 2, 
we compare the reported ICU patients with the predicted ICU patients based on the estimated parameters.
Based on the models with the estimated parameters, we now predict the future development of the number 
of ICU patients (see Fig. 3). Here, we will make a simplified assumption that the growth can be approximated 
Table 1.  Parameters for the best model fit separately for Berlin, Lombardy, and Madrid. T, number of days for 
which the model was fitted; α , ICU rate; K, stay in ICU; l∗ , time lag between positive testing and entering the 
ICU; (n)RMSE, (normalized) root mean squared error; ρ2 , squared correlation coefficient.
Region T α K l∗ RMSE (nRMSE) ρ2
Berlin 17 0.06 12 6 3.37 (20.82%) 0.98
Lombardy 17 0.18 3 0 54.01 (17.78%) 0.97
Madrid 22 0.15 8 3 39.50 (24.82%) 0.98
Figure 2.  Best model fit for the number of ICU patients with ICU rate α , stay in ICU K and time lag l∗ between 
positive testing and entering ICU, separately for Berlin, Lombardy, and Madrid.
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as either linear or exponential and hence demonstrate the effect of lower growth induced by containment meas-
ures. We show the sensitivity of the results for linear growth with the slope d between 0 and 2, 000 as well as 
exponential growth rates between 0 and 15%. A growth rate of 0% means that from one day to another, no more 
new infections are reported, which is an unrealistic extreme case. The other extreme, 15%, corresponds to a 
duplication of reported infections every 5 days. Please note that the daily growth rate in the last week before 
the strong containment measures came into force was 10% for Berlin, 23% for Lombardy, and 54% for Madrid.
In Fig. 3, the predicted number of ICU patients is additionally compared with the capacity limits introduced in 
the data section. A linear growth in the number of infections leads in the long-run to a constant number of ICU 
patients, which corresponds to α · d · K . This means, a share of α of the daily new infections d needs intensive 
care for K days. Regarding exponential growth, our estimated parameters show that for Berlin only growth rates 
between 0 and 4% guarantee that the number of patients at the end of May remains below the current maximal 
capacity, a rate of up to 5% guarantees to stay below the extended capacity by the end of May (but exceeds the 
Figure 3.  Predicted number of ICU patients assuming different linear (left) and exponential growth (right), 
separately for Berlin, Lombardy and Madrid. The black line corresponds to the true observations until seven 
days after the lockdown. The dashed black line indicates the estimates of capacity.
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capacity in June). For Lombardy and Madrid, it can be seen that the capacity was already exceeded before the 
containment measures came into force.
Figure 4 depicts the relation between different growth rates (0–15%) and the dates of capacity exceedance for 
exemplary capacities of 500, 1000, 1500, 2000, and 2500 for Berlin, Lombardy, and Madrid. It demonstrates how 
the approach can be applied also for different phases of exponential growth or capacity extensions.
Sensitivity analysis for an extended time period
Extended data until December 2020. To analyze the sensitivity of the model parameters, we extend the 
time series for all three regions until December 2020. While for Lombardy and Berlin, the same data as for the 
early phase are available until December 2020, we need to adapt the data for Madrid since consistent data were 
only available for the time period between August and December 2020. After the beginning of the pandemic in 
March/April 2020 and a decline of reported infections and ICU patients afterwards due to containment meas-
ures, all three regions experienced a second wave starting in September/October 2020 with strongly increasing 
numbers of reported infections and ICU patients (Fig. 5 in the Appendix).
Results of the sensitivity analysis. Table 2 depicts monthly estimates of the parameters and the good-
ness of fit if separate models are estimated for each calendar month from March (if available) to December 2020. 
It can be seen that the parameters vary over time, indicating structural breaks in the course of the pandemic. For 
example, the ICU rate α strongly decreases after the first wave, which can be explained by larger testing capacities 
and/or a better protection of people with pre-existing conditions or elderly people. In Berlin and Lombardy, the 
ICU rate seems to increase again with the second wave. Data for Berlin demonstrate that the age distribution of 
the reported infections changed significantly: Around 20% of reported infections in April and December belong 
to the group of 70 years old or older people, whereas this number goes down to 2% in August (own calculations 
based on data from LAGeSo Berlin25). Interestingly, the model fits are best in tipping points of the disease where 
the rates start to grow exponentially. For Berlin and Lombardy, the model fits best in March ( nRMSE = 18% , 
ρ2 = 0.99 for Berlin, nRMSE = 12% , ρ2 = 0.97 for Lombardy) and October ( nRMSE = 15% , ρ2 = 0.93 for 
Berlin, nRMSE = 13% , ρ2 = 0.99 for Lombardy), but the nRMSE goes up to 50% (Berlin) and 40% (Lombardy) 
in between. For Madrid, where we only have consistent data after the early phase, the lowest nRMSE has been 
found for September ( nRMSE = 19.15% , ρ2 = 0.78 ). These results highlight that the model is in particular suit-
able for exponential phases of the disease.
Figure 4.  Expected dates of capacity exceedance for different growth rates and exemplary capacities, separately 
for Berlin, Lombardy, and Madrid.
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Discussion
In this study, we provide a simple, comprehensible, and transparent model that allows for predicting ICU load 
assuming linear or different exponential growth of the number of infections depending on applied containment 
measures. We evaluated this model for Berlin, Lombardy, and Madrid, where we had access to the number of 
reported COVID-19 infections and ICU patients with COVID-19. Since the outbreaks are highly regional, we 
did not apply this model to larger areas such as whole countries. Based on data before extensive containment 
measures led to structural breaks, we first estimated the parameters ICU rate, length of stay in ICU, and time lag. 
For Berlin, an ICU rate of 6% was estimated which is close to an estimate of 5% in other  studies26,27 and expec-
tations of intensive care physicians in  Berlin28. An ICU rate of 5% has been reported based on data for 72,312 
cases in  China29. For Lombardy and Madrid, in contrast, a much higher ICU rate of 18% and 15%, respectively, 
resulted in the best model fit. This is in relative accordance with Grasselli et al.5 who reported an ICU rate of 16% 
for Lombardy in the first 2 weeks of the SARS-CoV-2 pandemic. In the sensitivity analysis, we have shown for 
Berlin and Lombardy that the ICU rate decreases to below 5% in the later months August to October/November 
probably due to a less restrictive testing scenario as in the  beginning22,30,31. In similar models, relying only on 
exponential growth of intensive care patients, ICU rates of 9–11% have been  assumed14.
Regarding the length of stay in ICU (until recovery or death), the best model fit resulted in 12 days for Berlin, 
3 days for Lombardy, and 8 days for Madrid. Whereas for Berlin and Madrid the numbers seems to be reason-
able, a stay of 3 days in Lombardy seems to be rather short. We think that this can be explained by the excessive 
demands on the health care system resulting in higher mortality rates and thus in a shorter length of stay in ICU. 
Based on data from China, other forecast models assumed an average stay of 8–10  days13,30. For Lombardy, a 
median length of ICU stay of 9 days has been reported for the early  phase32. Also for other regions in Italy and 
USA, longer ICU stays (about 15 days for ICU patients who remain alive and about 10–12 days for patients who 
die after ICU treatment) have been  found8,10. In New York, COVID-19 patients typically need ICU care with 
ventilation for 11–21 days, some patients stay in ICU for 30  days9.
The time lag between positive testing and ICU admission was estimated to be 6 for Berlin, 0 for Lombardy, 
and 3 for Madrid. The time lag is known to be highly variable because COVID-19 patients may be tested at dif-
ferent time points due to different disease courses as well as regulatory and organizational issues (e.g., capacity 
of test units or eligibility to get a test). Thus, the low numbers for Lombardy and Madrid can be explained by the 
limited testing capacity in those regions, where tests are mainly administered for patients with severe COVID-19 
 symptoms22,31. In addition, the extended time period analysis for Lombardy (see Fig. 5) revealed that the time 
lag seems to reflect the extent of demands on the ICU capacity by providing a time lag between 5 and 9 in times 
when the pressure was lower.
We then used the models with the estimated parameters to predict the number of ICU patients for a fixed 
time horizon of 2 months. By assuming linear or exponential growth of different levels and different ICU capaci-
ties, we evaluated different scenarios simulating the effect of containment measures and show the sensitivity 
Table 2.  Monthly estimates of ICU rate α , stay in ICU K, time lag between positive testing and entering the 
ICU l∗ , as well as model fit in terms of RMSE, normalized RMSE (nRMSE), and squared correlation ρ2 for the 
extended datasets.
Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Berlin
α 0.06 0.10 0.20 0.18 0.11 0.04 0.03 0.04 0.05 0.05
K 12 14 10 4 6 6 6 6 5 7
l∗ 6 0 8 0 9 4 6 8 4 7
RMSE 3.34 45.43 48.76 18.26 6.95 5.21 3.32 11.49 40.88 55.34
nRMSE (%) 17.93 31.97 49.59 45.19 31.42 32.19 19.93 15.04 15.13 15.49
ρ2 0.99 0.04 0.08 0.00 0.14 0.00 0.73 0.93 0.72 0.53
Lombardy
α 0.12 0.20 0.17 0.20 0.10 0.03 0.02 0.01 0.02 0.06
K 5 4 3 2 3 6 7 7 5 4
l∗ 1 6 9 5 6 9 5 2 9 4
RMSE 96.73 228.30 88.40 33.66 7.44 2.36 6.20 16.96 121.08 157.02
nRMSE (%) 12.23 22.28 28.60 40.78 30.09 18.18 21.06 13.00 15.55 24.02
ρ2 0.97 0.34 0.54 0.22 0.41 0.67 0.20 0.99 0.80 0.26
Madrid
α – – – – – – 0.02 0.04 0.05 0.04
K – – – – – – 6 6 6 5
l∗ – – – – – – 7 1 5 7
RMSE – – – – – – 70.28 96.76 92.17 112.43
nRMSE (%) – – – – – – 19.15 19.62 22.25 36.13
ρ2 – – – – – – 0.78 0.21 0.04 0.18
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towards the growth rate in the exponential phase of COVID-19. The further the expected dates of a capacity 
exceedance can be shifted into the future, the higher the likelihood that new treatments or a vaccination are 
available or that a larger share of the population has become immune against COVID-19, which would further 
lower the growth rate. The sensitivity analysis for the extended time series revealed that our model performs best 
in phases of the disease when the growth is exponential (first wave, second wave etc.) and might get inaccurate 
in non-exponential phases.
To account for the dynamic situation of the deployment of ICU beds, we compare the predicted number of 
ICU patients to different estimates of ICU capacity (if available). For simplicity, we assumed that all those beds 
are available for only COVID-19 patients and thus did not account for different utilization rates which might lead 
to an earlier capacity exceedance in practice. Additionally, we did not account for shortage in highly-qualified 
medical personnel. Already prior to the COVID-19 associated increase in capacities, it had been a common 
phenomenon that ICU beds were unused for lack of qualified  personnel33. Please note that we here also did not 
differentiate between high and low care ICUs (i.e., with and without invasive ventilator) since we only had num-
bers on the total number of ICU patients with COVID-19. Future studies might also try to account for changing 
treatment strategies of COVID-19 patients. Guidelines have  emerged34, but are likely subject to change. Early 
reports on the outbreak emphasized the potential progression of COVID-19 pneumonia to acute respiratory 
distress syndrome (ARDS)35, biasing towards early intubation and ventilation. However, a growing number 
of studies shows that a subgroup of patients seems to be clinically stable despite very low blood oxygenation 
levels and may benefit more from non-invasive oxygen supply and ventilation methods than early  intubation36. 
Accumulating experience with COVID-19 patients will therefore result in shifting treatment strategies that can 
either increase or ease the strain on ICU capacities.
By testing the proposed model for three regions, we show that this approach is generalizable to data of other 
cities and regions as long as the overall numbers of reported COVID-19 patients and the ICU capacities are 
available. We suppose here to use only regional data instead of summary data of whole countries since the occur-
rence of infections can be very diverse between different parts. When data on ICU patients with COVID-19 are 
additionally available, it can further be evaluated if our parameter estimates also hold true for other regions.
Although our predictions are based on a small data set and a number of assumptions, we introduced here 
a simple statistical model that (1) produces reasonable estimates for ICU rate, length of ICU stay, and time lag 
and (2) accounts for different exponential growth rates as well as linear growth with different slopes. Since our 
proposed model is quite generic, we hope that this study will help others to estimate the future need of intensive 
care in addition to sophisticated epidemiological approaches such as compartment or transmission  models30,37,38. 
Moreover, a simultaneous modelling for several neighboring regions (e.g., for whole Germany (DIVI register), 
Italy (PCM-DPC), Spain (Datadista), or France (Géodes database)) and a comparison of the results would be 
interesting. However, as already pointed out by  others13, any forecast models in early times of the current SARS-
CoV-2 pandemic needs to be taken with caution and assumptions need to be updated when further data become 
available. In particular, future studies might model the number of administered tests as a confounding variable.
Data availability
All data we used are public and can be downloaded from LAGeSo Berlin (https ://www.berli n.de/lages o/gesun 
dheit /infek tions epide miolo gie-infek tions schut z/coron a/) for Berlin, the Presidenza del Consiglio dei Ministri—
Dipartimento della Protezione Civile (https ://githu b.com/pcm-dpc/COVID -19) for Lombardy, and Datadista 
(https ://githu b.com/datad ista/datas ets) for Madrid.
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